Search research articles
Contact Us
Filters
Showing results (571-580 of 627) with videos related to
Page
of 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2019
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Joan L Walker, Mark F Brady, Lari Wenzel, et al.
Journal of Medicinal Chemistry
|
August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position
T J Tucker, S F Brady, W C Lumma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
Jung-Min Lee, Mark F Brady, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Larry J Copeland, Mark F Brady, Robert A Burger, et al.
Brain : a Journal of Neurology
|
June 6, 2018
Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development
Michael S Nahorski, Sateesh Maddirevula, Ryosuke Ishimura, et al.
Lancet (London, England)
|
August 1, 2017
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S Tewari, Michael W Sill, Richard T Penson, et al.
The Journal of Clinical Investigation
|
March 28, 2017
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans
Federica Buonocore, Peter Kühnen, Jenifer P Suntharalingham, et al.
American Journal of Human Genetics
|
May 31, 2016
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome
Stephen R F Twigg, Robert B Hufnagel, Kerry A Miller, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Page
of 63
Search research articles
Search
Showing results (571-580 of 627) with videos related to
Sort By:
Page
of 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2019
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Joan L Walker, Mark F Brady, Lari Wenzel, et al.
Journal of Medicinal Chemistry
|
August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position
T J Tucker, S F Brady, W C Lumma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
Jung-Min Lee, Mark F Brady, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Larry J Copeland, Mark F Brady, Robert A Burger, et al.
Brain : a Journal of Neurology
|
June 6, 2018
Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development
Michael S Nahorski, Sateesh Maddirevula, Ryosuke Ishimura, et al.
Lancet (London, England)
|
August 1, 2017
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S Tewari, Michael W Sill, Richard T Penson, et al.
The Journal of Clinical Investigation
|
March 28, 2017
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans
Federica Buonocore, Peter Kühnen, Jenifer P Suntharalingham, et al.
American Journal of Human Genetics
|
May 31, 2016
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome
Stephen R F Twigg, Robert B Hufnagel, Kerry A Miller, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Page
of 63